Metabolic evaluation and recurrence prevention for urinary stone patients: EAU guidelines

Context: An optimum metabolic evaluation strategy for urinary stone patients has not been clearly defined. Objective: To evaluate the optimum strategy for metabolic stone evaluation and management to prevent recurrent urinary stones. Evidence acquisition: Several databases were searched to identify...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Skolarikos, Andreas (VerfasserIn) , Knoll, Thomas (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: April 2015
In: European urology
Year: 2015, Jahrgang: 67, Heft: 4, Pages: 750-763
ISSN:1873-7560
DOI:10.1016/j.eururo.2014.10.029
Online-Zugang:Verlag, Volltext: http://dx.doi.org/10.1016/j.eururo.2014.10.029
Verlag, Volltext: http://www.sciencedirect.com/science/article/pii/S0302283814011026
Volltext
Verfasserangaben:Andreas Skolarikos, Michael Straub, Thomas Knoll, Kemal Sarica, Christian Seitz, Ales Petřík, Christian Türk

MARC

LEADER 00000caa a2200000 c 4500
001 158498435X
003 DE-627
005 20230427161341.0
007 cr uuu---uuuuu
008 181207s2015 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.eururo.2014.10.029  |2 doi 
035 |a (DE-627)158498435X 
035 |a (DE-576)51498435X 
035 |a (DE-599)BSZ51498435X 
035 |a (OCoLC)1341024644 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Skolarikos, Andreas  |e VerfasserIn  |0 (DE-588)1172311463  |0 (DE-627)1041112750  |0 (DE-576)514503173  |4 aut 
245 1 0 |a Metabolic evaluation and recurrence prevention for urinary stone patients  |b EAU guidelines  |c Andreas Skolarikos, Michael Straub, Thomas Knoll, Kemal Sarica, Christian Seitz, Ales Petřík, Christian Türk 
264 1 |c April 2015 
300 |a 14 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Available online 20 November 2014 
500 |a Gesehen am 07.12.2018 
520 |a Context: An optimum metabolic evaluation strategy for urinary stone patients has not been clearly defined. Objective: To evaluate the optimum strategy for metabolic stone evaluation and management to prevent recurrent urinary stones. Evidence acquisition: Several databases were searched to identify studies on the metabolic evaluation and prevention of stone recurrence in urolithiasis patients. Special interest was given to the level of evidence in the existing literature. Evidence synthesis: Reliable stone analysis and basic metabolic evaluation are highly recommended in all patients after stone passage (grade A). Every patient should be assigned to a low- or high-risk group for stone formation. It is highly recommended that low-risk stone formers follow general fluid and nutritional intake guidelines, as well as lifestyle-related preventative measures to reduce stone recurrences (grade A). High-risk stone formers should undergo specific metabolic evaluation with 24-h urine collection (grade A). More specifically, there is strong evidence to recommend pharmacological treatment of calcium oxalate stones in patients with specific abnormalities in urine composition (grades A and B). Treatment of calcium phosphate stones using thiazides is only highly recommended when hypercalciuria is present (grade A). In the presence of renal tubular acidosis (RTA), potassium citrate and/or thiazide are highly recommended based on the relative urinary risk factor (grade A or B). Recommendations for therapeutic measures for the remaining stone types are based on low evidence (grade C or B following panel consensus). Diagnostic and therapeutic algorithms are presented for all stone types based on the best level of existing evidence. Conclusion: Metabolic stone evaluation is highly recommended to prevent stone recurrences. Patient summary: In this report, we looked at how patients with urolithiasis should be evaluated and treated in order to prevent new stone formation. Stone type determination and specific blood and urine analysis are needed to guide patient treatment. 
650 4 |a European Association of Urology 
650 4 |a Guidelines 
650 4 |a Lithiasis 
650 4 |a Medical treatment 
650 4 |a Metabolic evaluation 
650 4 |a Recurrence and conservative treatment 
650 4 |a Stone 
650 4 |a Urinary 
700 1 |a Knoll, Thomas  |d 1971-  |e VerfasserIn  |0 (DE-588)143556045  |0 (DE-627)704527839  |0 (DE-576)337679932  |4 aut 
773 0 8 |i Enthalten in  |t European urology  |d Amsterdam [u.a.] : Elsevier Science, 1976  |g 67(2015), 4, Seite 750-763  |h Online-Ressource  |w (DE-627)300191596  |w (DE-600)1482253-2  |w (DE-576)099718103  |x 1873-7560  |7 nnas  |a Metabolic evaluation and recurrence prevention for urinary stone patients EAU guidelines 
773 1 8 |g volume:67  |g year:2015  |g number:4  |g pages:750-763  |g extent:14  |a Metabolic evaluation and recurrence prevention for urinary stone patients EAU guidelines 
856 4 0 |u http://dx.doi.org/10.1016/j.eururo.2014.10.029  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u http://www.sciencedirect.com/science/article/pii/S0302283814011026  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20181207 
993 |a Article 
994 |a 2015 
998 |g 143556045  |a Knoll, Thomas  |m 143556045:Knoll, Thomas  |d 60000  |e 60000PK143556045  |k 0/60000/  |p 3 
999 |a KXP-PPN158498435X  |e 303694026X 
BIB |a Y 
SER |a journal 
JSO |a {"relHost":[{"pubHistory":["Nachgewiesen 2.1976 -"],"title":[{"subtitle":"official organ of the European Association of Urology, the European Organization for Research and Treatment of Cancer - Genito-Urinary Group, the European Society for Urological Oncology and Endocrinology","title":"European urology","title_sort":"European urology"}],"origin":[{"dateIssuedDisp":"1976-","publisher":"Elsevier Science ; Karger","publisherPlace":"Amsterdam [u.a.] ; Basel","dateIssuedKey":"1976"}],"language":["eng"],"part":{"extent":"14","year":"2015","volume":"67","pages":"750-763","text":"67(2015), 4, Seite 750-763","issue":"4"},"physDesc":[{"extent":"Online-Ressource"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"disp":"Metabolic evaluation and recurrence prevention for urinary stone patients EAU guidelinesEuropean urology","recId":"300191596","id":{"eki":["300191596"],"zdb":["1482253-2"],"issn":["1873-7560","1421-993X"]},"note":["Ungezählte Beil. bis 40.2001: Supplement"]}],"language":["eng"],"recId":"158498435X","name":{"displayForm":["Andreas Skolarikos, Michael Straub, Thomas Knoll, Kemal Sarica, Christian Seitz, Ales Petřík, Christian Türk"]},"note":["Available online 20 November 2014","Gesehen am 07.12.2018"],"id":{"eki":["158498435X"],"doi":["10.1016/j.eururo.2014.10.029"]},"person":[{"given":"Andreas","roleDisplay":"VerfasserIn","role":"aut","family":"Skolarikos","display":"Skolarikos, Andreas"},{"given":"Thomas","roleDisplay":"VerfasserIn","role":"aut","display":"Knoll, Thomas","family":"Knoll"}],"physDesc":[{"extent":"14 S."}],"title":[{"title_sort":"Metabolic evaluation and recurrence prevention for urinary stone patients","title":"Metabolic evaluation and recurrence prevention for urinary stone patients","subtitle":"EAU guidelines"}],"origin":[{"dateIssuedKey":"2015","dateIssuedDisp":"April 2015"}],"type":{"media":"Online-Ressource","bibl":"article-journal"}} 
SRT |a SKOLARIKOSMETABOLICE2015